<DOC>
	<DOCNO>NCT01856049</DOCNO>
	<brief_summary>Cell-based cardiac regeneration focus acquire , adult heart disease many year . However , congenital heart disease severe structural abnormality may also reasonable target cell-based therapy . Interestingly , pediatric heart naturally grow may amendable regenerative strategy . Therefore , identify autologous cell ( cell patient 's body ) would important initiate study . This study aim validate use umbilical cord blood source autologous cell purpose cardiac repair congenital heart disease . Cells isolate cord blood help u determine feasibility collection , processing , storage sample time birth infant prenatal diagnosis hypoplastic leave heart syndrome . This study may useful development pre-clinical clinical study aim long-term goal repair damage heart muscle .</brief_summary>
	<brief_title>Umbilical Cord Blood Collection Processing Cardiac Regeneration Hypoplastic Left Heart Syndrome Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
	<criteria>Any pregnant woman , regardless age , prenatal diagnosis HLHS One parent willing consent storage umbilical cord blood specific purpose regenerative research Mother willing provide blood sample serology test Individuals unwilling participate</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>HLHS</keyword>
	<keyword>Hypoplastic Left Heart Syndrome</keyword>
	<keyword>UCB ( umbilical cord blood )</keyword>
	<keyword>Umbilical cord blood</keyword>
	<keyword>Cord blood</keyword>
	<keyword>Cardiac regeneration</keyword>
</DOC>